EBIT: Income before interest and taxes.
Harvard Bioscience, Inc. (HBIO) had EBIT of $-1.17M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$20.75M |
|
$-3.42M |
|
$8.51M |
|
$12.24M |
|
$21.93M |
|
$-1.17M |
|
$-2.13M |
|
$-3.31M |
|
$-3.31M |
|
$-3.42M |
|
$-3.42M |
|
$-3.42M |
|
$-3.42M |
|
|
EBIT |
$-1.17M |
$0.62M |
|
4.47M |
|
4.47M |
|
$-0.77 |
|
$-0.77 |
|
| Balance Sheet Financials | |
$47.48M |
|
$4.87M |
|
$30.46M |
|
$77.94M |
|
$23.86M |
|
$36.21M |
|
$44.03M |
|
$67.89M |
|
$10.05M |
|
$-6.23M |
|
$10.05M |
|
4.51M |
|
| Cash Flow Statement Financials | |
$-0.66M |
|
$-0.62M |
|
$-0.01M |
|
$8.61M |
|
$7.10M |
|
$-1.52M |
|
$0.26M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.99 |
|
-- |
|
-- |
|
0.78 |
|
3.60 |
|
58.99% |
|
-5.66% |
|
-5.66% |
|
-- |
|
-15.93% |
|
-16.50% |
|
$-1.09M |
|
-- |
|
-- |
|
-- |
|
0.27 |
|
0.38 |
|
1.42 |
|
63.19 |
|
-34.08% |
|
54.94% |
|
-4.39% |
|
-7.40% |
|
$2.23 |
|
$-0.24 |
|
$-0.15 |
|